Amgen's most recent trend suggests a bearish bias. One trading opportunity on Amgen is a Bear Call Spread using a strike $170.00 short call and a strike $175.00 long call offers a potential 13.9% return on risk over the next 10 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $170.00 by expiration. The full premium credit of $0.61 would be kept by the premium seller. The risk of $4.39 would be incurred if the stock rose above the $175.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Amgen is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Amgen is bearish.
The RSI indicator is at 55.59 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
Equity markets fell…and fell hard (no recovery like yesterday)
Wed, 10 Dec 2014 22:15:00 GMT
Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data
Wed, 10 Dec 2014 19:10:56 GMT
Amgen Successfully Expands Xgeva Label in the U.S.
Tue, 09 Dec 2014 21:00:01 GMT
Big-Cap Stock Funds Tend To Lag
Tue, 09 Dec 2014 13:02:00 GMT
3:15 am Amgen presents data from pivotal Phase 2 Study Of BLINCYTO Immunotherapy In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Tue, 09 Dec 2014 08:15:00 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook